Skip to content
Clinical Trials – home

Brimonidine: A Comprehensive Guide for Patients

0 / 1
trials open to patients / all trials
1+
Countries

In short

Brimonidine, a medication used in various ophthalmic formulations, has been the subject of numerous clinical trials investigating its efficacy in treating a range of eye conditions. These studies have explored different concentrations and applications of brimonidine, from reducing ocular redness to managing symptoms of ocular graft-versus-host disease. This article summarizes key findings from recent clinical trials, highlighting the potential benefits and diverse uses of brimonidine in ophthalmology.

What is Brimonidine?

Brimonidine is a medication that belongs to a class of drugs called alpha-2 adrenergic agonists. It is primarily used in ophthalmology (eye medicine) for various conditions. Brimonidine is known by several brand names, including Alphagan-P, Mirvaso, and Lumify, depending on its concentration and specific use.

Conditions Treated with Brimonidine

Brimonidine is used to treat several eye-related conditions:

  • Glaucoma: Brimonidine is commonly used to lower intraocular pressure (pressure inside the eye) in patients with open-angle glaucoma or ocular hypertension.
  • Rosacea: A topical gel form of brimonidine (Mirvaso) is approved for treating facial erythema (redness) associated with rosacea in adults.
  • Eye Redness: Over-the-counter brimonidine eye drops (Lumify) are used to relieve eye redness due to minor eye irritations.
  • Ocular Graft-vs-Host Disease (oGVHD): Research is ongoing to evaluate brimonidine's effectiveness in treating this condition, which can occur after bone marrow transplants.

How Brimonidine Works

Brimonidine works in different ways depending on its use:

  • For glaucoma, it reduces the production of aqueous humor (the clear fluid inside the eye) and increases its outflow, thereby lowering intraocular pressure.
  • For rosacea and eye redness, brimonidine acts as a vasoconstrictor, narrowing blood vessels in the eye or skin to reduce redness.
  • In oGVHD, brimonidine may help relieve inflammation and dryness associated with the condition.

Forms and Dosages

Brimonidine comes in several forms and concentrations:

  • Eye drops: Available in concentrations of 0.1%, 0.15%, and 0.2% for glaucoma treatment.
  • Over-the-counter eye drops: 0.025% concentration for relieving eye redness.
  • Topical gel: 0.33% concentration for facial redness in rosacea.

The dosage and frequency of application depend on the condition being treated and should be determined by a healthcare professional.

Ongoing Research and Potential New Uses

Researchers are exploring new potential uses for brimonidine:

  • Hand-Foot Syndrome: A study is investigating whether topical brimonidine can reduce symptoms of hand-foot syndrome, a side effect of some cancer treatments.
  • Pterygium Surgery: Brimonidine is being studied for its potential to reduce bleeding during eye surgery for pterygium, a growth on the eye's surface.
  • Presbyopia: Brimonidine is being investigated as part of a combination eye drop treatment for presbyopia, an age-related condition affecting near vision.

Potential Side Effects

Like all medications, brimonidine can cause side effects. Common side effects may include:

  • Eye irritation, burning, or stinging
  • Dry eyes
  • Blurred vision
  • Headache
  • Drowsiness

Less common but more serious side effects can include allergic reactions, changes in heart rate or blood pressure, and worsening of depression. It's important to discuss any side effects with your healthcare provider.

Questions people often ask

Conditions where Brimonidine is being studied

Each condition opens its own overview and trial list

Trials with Brimonidine

Recruiting trials first

See all 1 →
Quick filters
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.